Penbrook Management’s Calumet Specialty Products CLMT Stock Holding History

Penbrook Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-82,781	Closed	-$2.63M	–	123
2014 Q2	$2.63M	Sell	82,781 -84,381	-50%	-$2.51M	2.32%	5
2014 Q1	$4.33M	Buy	167,162 +83,581	+100%	+$2.28M	2.08%	10
2013 Q4	$2.17M	Buy	+83,581	New	+$2.34M	2.11%	10

Other funds holding CLMT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

IMS

Index Management Solutions Philadelphia, Pennsylvania $101M AUM 12.09% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Corrado Advisors Ramsey, New Jersey $217M AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Penbrook Management's CLMT Position: Q3 2014 in Review

Penbrook Management sold out of Calumet Specialty Products (CLMT) in Q3 2014, closing a stake of 82,781 shares — an estimated $2.63M sold.

Penbrook Management first reported a position in CLMT in Q4 2013 and held it in 3 quarters. The position peaked at $4.33M in Q1 2014. 115 funds tracked by Wall St. Rank hold CLMT as of Q3 2014.

Penbrook Management reported no remaining Calumet Specialty Products position as of Q3 2014 after selling out during the quarter.
Penbrook Management sold 82,781 Calumet Specialty Products shares in Q3 2014, an estimated $2.63M.
Penbrook Management first reported a position in Calumet Specialty Products in Q4 2013 and held it in 3 quarters.
Penbrook Management's Calumet Specialty Products position peaked at $4.33M in Q1 2014.
115 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2014.

Based on Penbrook Management's 13F filing for Q3 2014, filed 16 Oct 2014.